| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 07/02/2009 | CA2710151A1 Substituted 4-{3-[6-amino-9-(3,4-dihydroxy-tetrahydro-furan-2-yl)-9h-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as a2ar agonists |
| 07/02/2009 | CA2710016A1 Translocator protein ligands |
| 07/01/2009 | EP2074143A1 Altered antibodies |
| 07/01/2009 | EP1648224B1 Rat model of diabetic nephropathy |
| 07/01/2009 | EP1315417B1 Mutant non-human mammal for expressing the alpha6 acetylcholine nicotinic receptor subunit and use for screening substances capable of interacting with said receptor |
| 07/01/2009 | EP1263325B1 Embolic agents visible under ultrasound |
| 07/01/2009 | CN100506286C Method, compounds and preparations for the identification of sentinel lymph nodes |
| 06/30/2009 | US7555334 Small animal light intensity monitor |
| 06/30/2009 | US7553631 RBP4 in insulin sensitivity/resistance, diabetes, and obesity |
| 06/30/2009 | US7553479 Heat stable colloidal iron oxides coated with reduced carbohydrates and uses thereof |
| 06/30/2009 | US7553478 Methods for diagnosing and monitoring treatment ADHD by assessing the dopamine transporter level |
| 06/30/2009 | CA2407654C Liposome containing hydrophobic iodine compound |
| 06/30/2009 | CA2259421C Labelling and selection of molecules |
| 06/25/2009 | WO2009079554A1 Novel pharmaceutical compositions and methods of preparation and use |
| 06/25/2009 | WO2009078977A2 Compositions and methods to concurrently treat or prevent multiple diseases with cupredoxins |
| 06/25/2009 | WO2009078000A2 Imaging dyes and use thereof |
| 06/25/2009 | WO2009077908A1 Colloidal particle comprising multivalent cyclic anions |
| 06/25/2009 | WO2009077750A1 Fluorescent marker for cell death in the eye |
| 06/25/2009 | WO2009077671A1 Solid inorganic/organic hybrid with modified surface |
| 06/25/2009 | WO2009077670A1 Organic/inorganic hybrid nanoparticulates made from iron carboxylates |
| 06/25/2009 | WO2009077586A2 Methods and compositions for the preparation and use of toxin conjugates |
| 06/25/2009 | WO2009077575A1 Composition and method for generating a metabolic profile using 13c-mr detection |
| 06/25/2009 | WO2009053876A3 Nir emitters excitable in the visible spectral range and their application in biochemical and medical imaging |
| 06/25/2009 | US20090163529 Identifying therapeutic compounds based on their physical-chemical properties |
| 06/25/2009 | US20090162933 Epha2 and hyperproliferative cell disorders |
| 06/25/2009 | US20090162890 Identifying therapeutic compounds based on their physical-chemical properties |
| 06/25/2009 | US20090162328 In vivo assay and molecular markers for testing the phenotypic stability of cell populations and selected cell populations for autologous transplantation |
| 06/25/2009 | US20090162293 Methods and compositions for ultrasound imaging of apoptosis |
| 06/25/2009 | US20090162292 Substituted 4--piperidine-1-carboxylic acid esters as a2ar agonists |
| 06/25/2009 | US20090162291 Magnetic resonance contrast medium using polyethylene glycol and magnetic resonance image pick-up method |
| 06/25/2009 | US20090162290 Method for the synthesis of penta-pendant enantiomer-pure chelators and process for therapeutically active bioconjugates preparation by a covalent binding thereof |
| 06/25/2009 | US20090162289 A tetrapyrollic photosensitizer compound with one pendant CH2CH2CON(CH2CON(CH2COOH)2)2 or N(CH2COOH)2 group, being a chlorin, bacteriochlorin, porphyrin, pyropheophorbide, purpurinimide, or bacteriopurpurinimide; water soluble photosensitizing and imaging compounds; hyperproliferative tissue |
| 06/25/2009 | US20090162288 Use of modified vaccinia virus strains in combination with a chemotherapeutic agent for use in therapeutic methods |
| 06/25/2009 | US20090162285 Anti-inflammatory fusion protein |
| 06/25/2009 | US20090162284 Anti-igf-i receptor antibody |
| 06/25/2009 | US20090162281 Radionuclide labeling of Vitamin B12 and Co-enzymes thereof |
| 06/25/2009 | US20090162280 Detecting soluble a-beta |
| 06/25/2009 | US20090162277 Lysophospholipids Solubilized Single-Walled Carbon Nanotubes |
| 06/25/2009 | US20090162276 Medical devices containing melt-blown non-wovens of poly-4-hydroxybutyrate and copolymers thereof |
| 06/25/2009 | US20090162275 Contrast agents anchored by thiols on nanoparticles |
| 06/25/2009 | CA2709253A1 Fluorescent marker for cell death in the eye |
| 06/25/2009 | CA2699496A1 Solid inorganic/organic hybrid with modified surface |
| 06/25/2009 | CA2699480A1 Organic/inorganic hybrid nanoparticulates made from iron carboxylates |
| 06/24/2009 | EP2072062A1 The use of the spin crossover complex [M*+ (L2) Hw]AN)2 as a magnetic resonance imaging contrast agent |
| 06/24/2009 | EP2072061A1 Composition and method for generating a metabolic profile using 13C-MR detection |
| 06/24/2009 | EP1224861B1 Test method relating to adipose cells and to obesity by using a human h-pgds overexpressing non-human animal |
| 06/24/2009 | EP1126785B1 Manganese compositions and methods for mri |
| 06/24/2009 | CN101466411A Elimination of contrast agent concentration dependency in MRI |
| 06/24/2009 | CN101466410A Novel therapeutic and diagnostic products and methods |
| 06/23/2009 | US7550587 Photosensitizer and method for production thereof |
| 06/23/2009 | US7550272 Method for diagnosis of pancreatic exocrine function |
| 06/23/2009 | US7550150 Methods of treating or preventing a disease, disorder or condition associated with a viral infection |
| 06/23/2009 | US7550140 Stimulation of human T-cells and used to enhance antigen-specific immune responses; immunotherapy |
| 06/23/2009 | CA2337113C Methods and devices for reducing the mineral content of vascular calcified lesions |
| 06/23/2009 | CA2329014C Mr signal-emitting coatings |
| 06/23/2009 | CA2304820C Stabilized bioactive preparations and methods of use |
| 06/18/2009 | WO2009074811A2 Use of 5-aminolevulinic acid and derivatives in a solid form for photodynamic treatment and diagnosis |
| 06/18/2009 | WO2009074628A1 Polypeptides, cyclic polypeptides and pharmaceutical comprising thereof for non invasive specific imaging of fibrosis |
| 06/18/2009 | WO2009073984A1 High-density lipoprotein-like peptide-phospholipid scaffold ('hpps') nanoparticles |
| 06/18/2009 | WO2009036441A3 Contrast agents |
| 06/18/2009 | WO2009034177A3 Diagnostic substances for optical imaging testing on the basis of nanoparticular formulations |
| 06/18/2009 | WO2008141107A8 Compositions that include a hydrophobic compound and a polyamino acid conjugate |
| 06/18/2009 | US20090155184 Magnetic resonance imaging method |
| 06/18/2009 | US20090155183 Sensors for the detection of diols and carbohydrates |
| 06/18/2009 | US20090155182 Optical in vivo imaging contrast agents and methods of use |
| 06/18/2009 | US20090155180 Methods and targets for identifying compounds for regulating rhinovirus infection |
| 06/18/2009 | US20090155179 Kinetic biomarker for quantification of lymphoproliferation, clonal expansion, recruitment and trafficking in lymphoid tissues and of the in vivo actions of antigens and modulating thereon |
| 06/18/2009 | US20090155178 Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy |
| 06/18/2009 | US20090155177 Phthalocyanine dyes and their preparation and use |
| 06/18/2009 | US20090155176 Compositions and methods for treatment of diabetic retinopathy |
| 06/18/2009 | US20090155175 Simultaneous transluminal coronary sinus application of cells in conjunction with device resynchronization therapy |
| 06/18/2009 | US20090155174 RNA Interference Mediating Small RNA Molecules |
| 06/18/2009 | US20090155173 Persistent luminescence nanoparticles used in the form of a diagnosis agent for in vivo optical imaging |
| 06/18/2009 | US20090155172 Antibodies to MAGMAS and uses thereof |
| 06/18/2009 | US20090155171 Visualizing agent comprising a janus green b and visualizing method by using the same |
| 06/18/2009 | US20090155170 Annexin derivatives suitable for pretargeting in therapy and diagnosis |
| 06/18/2009 | US20090155169 Glyco-molecular imaging method for grade classification of liver fibrosis and its glyco-molecular imaging agent thereof |
| 06/18/2009 | US20090155165 Anti-igf-i receptor antibody |
| 06/18/2009 | DE102007059752A1 Funktionalisierte, feste Polymernanopartikel enthaltend Epothilone Functionalized solid polymer nanoparticles comprising epothilones |
| 06/18/2009 | CA2708719A1 High-density lipoprotein-like peptide-phospholipid scaffold ("hpps") nanoparticles |
| 06/18/2009 | CA2708137A1 Use |
| 06/17/2009 | EP2070551A1 Improved thickened beverages for dysphagia |
| 06/17/2009 | EP2068940A2 Mri trackable drug delivery particles, uses and methods thereof |
| 06/17/2009 | EP2068939A2 Methods of screening agents for activity using teleosts |
| 06/17/2009 | EP2068938A2 Method of optimizing the treatment of philadelphia-positive leukemia with abl tyrosine kinase inhibitors |
| 06/17/2009 | EP1579506A4 Water soluble metal and semiconductor nanoparticle complexes |
| 06/17/2009 | CN101460199A Systems and methods for cell measurement utilizing ultrashort T2* relaxometry |
| 06/17/2009 | CN101455848A Method of screening tumor metastasis suppressor gene using RNA interference library |
| 06/17/2009 | CN101455847A Use of ESAT6and CFP10 protein in preparing medicine for diagnosing tuberculosis |
| 06/17/2009 | CN100500223C Acoustical contrast medium of polymer material and its preparation method |
| 06/16/2009 | US7547689 Motexafin gadolinium or lutetium for injection in sealed glass vial purged of oxygen; radiation sensitizer acts to catalyze the oxidation of NAD(P)H, ascorbate and other reducing agents |
| 06/16/2009 | US7547530 Nucleotide compositions comprising photocleavable markers and methods of preparation thereof |
| 06/16/2009 | US7547442 Newcastle disease virus infectious clones, vaccines and new diagnostic assays |
| 06/16/2009 | CA2304975C Stabilized preparations for use in metered dose inhalers |
| 06/11/2009 | WO2009073896A2 Nano-scale contrast agents and methods of use |
| 06/11/2009 | WO2009072882A1 Animals of the rattus genus wherein msh6 expression is functionally decreased and methods for the generation of specific mutants there from |
| 06/11/2009 | WO2009072361A1 Composition for in vivo fluorescence test, method of testing breast cancer tissue using the same and method of imaging and observing diseased body tissue |
| 06/11/2009 | WO2009072079A2 Polymeric drug carrier for image-guided delivery |
| 06/11/2009 | WO2009072074A1 Chelating agent derivatives and compositions comprising the same for use in imaging methods |
| 06/11/2009 | WO2009071605A1 Contrast agents |